By Monica Heger
The goal is to find personalized biomarkers in the immune system that will lead to better and earlier diagnostics.
T-cell receptor sequencing is "a long way from being used clinically," said Robert Holt, head of sequencing at the BC Cancer Agency's Genome Sciences Center and senior author of a recent paper on the subject.
The company has opened a San Francisco office to provide bioinformatics development and analysis services to life science customers in the area.
The company said that it will eventually provide diagnostic and prognostic tests, as well as monitoring, for infection, auto-immune diseases, and cancer.
Leveraging the "absurd revolution in DNA sequencing costs" over the past decade, the San Francisco-based firm is developing an assay for interrogation of the immune repertoire.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.